Skip to main content
Fig. 1 | BMC Medical Genomics

Fig. 1

From: MiR-455-3p inhibits gastric cancer progression by repressing Wnt/β-catenin signaling through binding to ARMC8

Fig. 1

Expression of miR-455-3p is altered in GC tissues and cells (A) Expression level of miR-455-3p in GC tissues compared with adjacent non-tumor tissues in TCGA STAD dataset. B Expression of miR-455-3p in in human GC tissues and adjacent tissues. C Expression of miR-455-3p in GES-1, HGC-27, and AGS cells. Data are representative of three independent experiments. Statistical significance was evaluated using Student’s t tests. Data are presented as the mean ± SD. *p < 0.05, **p < 0.01, ***p < 0.001

Back to article page

BMC Medical Genomics

ISSN: 1755-8794

Contact us